Looks like no one added any tags here yet for you.
What is hematologic malignancies?
§ Cancer that begins in blood forming tissue.
What is hematopoiesis?
§ The production of all blood cells beginning in the bone marrow.
True/False: the clinical presentation of hematologic malignancies depend on the type of hematologic malignancy.
-True
What would be the clinical presentation of a hematologic malignancy if a patient has pancytopenia?
§ They will feel fatigue.
§ Infections
§ Gingival bleeding
§ Epistaxis
What would be the clinical presentation of a hematologic malignancy if a patient has leukicytosis?
§ Splenomegaly ( enlarged spleen).
§ Bone pain
What would be the clinical presentation of a hematologic malignancy if a patient has leukostasis?
§ Abdominal pain from splenic infarctions
§ Priapism
§ Hemorrhage
What are some constitutional ( common) symptoms of hematologic malignancies?
§ Fatigue
§ Weight loss
§ Anorexia
§ Elevated temperature ( can be from the disease or signs of infection).
What can happen to a patient if their hematologic malignancy spreads to the brain?
§ It can cause confusion and motor impairment.
Where does leukemia occur?
in the leukocytes( WBCs)
What are some types of leukemia’s?
o Chronic Myeloid Leukemia: CML
o Acute Lymphocytic Leukemia (ALL)
o Acute Myeloid Leukemia (AML)
Where do lymphoma’s occur?
-in the lymphatic system
What are some types of Lymphoma’s?
o Hodgkin’s Lymphoma
o Non-Hodgkin’s Lymphoma ( Diffuse Large B-cell, Burkitt’s, Mantle Cell, Follicular)
Where does multiple myeloma take place?
it happens in the plasma cells
Which cancers originate from the myeloid lineage?
§ Acute myeloid leukemia ( AML ) and other related neoplasms
§ Myelodysplastic syndrome (MDS)
§ Chronic myeloid leukemia
§ Chronic neutrophilic leukemia
§ Chronic eosinophilic leukemia
When a patient is getting their CBCs taking what cell line are they taking from?
§ Myeloid progenitor cells
What are the cells of the myeloid Lineage Cell Line?
§ Myeloid Progenitor Cell:
· Erythroblast:
o Erythrocytes ( RBCs)
· Megakaryoblast:
o Platelets
· Myeloblast:
o Neutrophils
o Basophils
o Eosinophils
· Monoblasts:
o Monocytes
o Macrophages
Myeloid dendritic cells
Which cancers originate from the lymphoid neoplasms lineage?
§ Hodgkin’s Lymphoma
§ Diffuse Large B- cell lymphoma
§ Burkitt lymphoma/leukemia
§ Follicular lymphoma
§ Mantle cell lymphoma
§ Multiple Myeloma
What are the cells of the Lymphoid Cell Lineage?
§ Lymphoid Progenitor Cell:
· Pre-B cell:
o B-lymphocytes – Plasma cells
· Pre-T cell:
o T-lymphocytes
How would a healthcare provider diagnose/stage a person with hematologic malignancies?
§ 1st you take a CBC ( complete blood count).
§ 2nd you do a bone marrow biopsy and aspirate:
· Flow cytometry:
o Used to detect and measure physical and chemical characteristics of a population of cell particles.
· Cytogenetics:
o Study of chromosomes ( you study the number and appearance of the chromosomes)
· Immunophenotyping:
o Identify cells based on the types of markers or antigens present on the cell’s surface, nucleus, or cytoplasm.
§ 3rd you can do a lumbar puncture to determine if there is disease in the central nervous system.
What are the treatment options used in the healthcare system today to treat hematologic malignancies?
§ Chemotherapy
§ Targeted therapy
§ Immunotherapy:
· Destroy the cancer cells while minimizing effects on healthy cells.
What are the treatment stages used in order to help treat hematologic malignancies?
§ Induction stage:
· Administer medication to eradicate cancer cells.
§ Consolidation stage:
· Administer medication with a complete remission ( disappearance of all cancer)
· Eradicates any remaining disease.
§ Maintenance stage:
· Sometimes administer medication after consolidation to prevent cancer from recurring.
After a patient has received treatment for their hematologic cancer, what would you look for in order to say that the patient had a complete response to treatment:
§ Disappearance of all clinical and BM evidence.
§ Most patients achieve after 1 or 2 courses of chemotherapy.
What things would you look for after hematologic malignancy treatment to say that a patient had a partial remission to treatment?
§ Significant response to treatment ( a decrease of greater than or equal to 50% of blasts) but evidence of residual disease in BM remains ( 5-25% blasts).
§ Considered a treatment failure requiring additional therapy.
After a patient has received treatment from their hematologic malignancy, what would a healthcare provider consider to be a relapse in treatment:
§ Return of disease or the signs/symptoms of disease after a period of improvement.
When a healthcare provider says that a patient had a refractory response to treatment, what do they mean?
-the patient did not respond to therapy.
Describe the steps of the Bone Marrow Transplant process:
§ Type of HCT
§ Stem cell collection
§ Conditioning chemotherapy
§ Cell infusion
§ Engraftment
§ Post HCT care
What can be a complication of allogenic HCT?
§ Graft Versus Host Disease ( GCHD):
· Body fights itself.
· Acute ( within 3 months post-transplant)
· Chronic ( within 1 year of transplant)
· Risk factors:
o Mismatched donor
o Unrelated donor
o Increased age
o Previous acute GVHD
What are things patients take as bone marrow treatment aftercare?
§ Take immunosuppressants.
§ Take steroids.
§ Get vaccinations. ( giving between 18-24 months’ time span)